|Bid||103.9100 x 100|
|Ask||105.0200 x 100|
|Day's Range||102.4946 - 106.6500|
|52 Week Range||42.3700 - 110.2500|
|PE Ratio (TTM)||56.51|
|Earnings Date||Aug 1, 2017 - Aug 7, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||98.42|
"Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, announced today that it has entered into a new $30 million credit agreement with JPMorgan Chase, Inc. The credit agreement matures in July 2020 and replaces the Company's existing $15 million asset based line of credit. The new facility, which may be increased by an additional $20 million subject to conditions, provides access to a new revolving credit facility that can be used for general working capital, capital investments and acquisitions. John McMahon, Vice President and Chief Financial Officer of Heska, stated, "As Heska pursues strategic growth opportunities, the incremental liquidity, enhanced flexibility, and expandability of this new credit facility represents another key piece in place for Heska.
LOVELAND, Colo. , July 20, 2017 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a provider of advanced veterinary diagnostic and specialty products, ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Heska Corp. Here are 5 ETFs with the largest exposure to HSKA-US. Comparing the performance and risk of Heska Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)